Matthew C. Darch

Mergers & Acquisitions

• Allergan Aesthetics, an AbbVie company (NYSE: ABBV), in its pending $550 million acquisition of Soliton (NASDAQ: SOLY), a medical technology company focused on developing and commercializing products utilizing its proprietary designed acoustic shockwave technology platform referred to as RAP
• Bristol Myers Squibb in its $13.4 billion divesture of Celgene’s OTEZLA® program to Amgen
• The Carlyle Group:
  
  • in partnership with Unchained Labs’ management, in the $435 million acquisition of Unchained Labs, a life science tools company, from Novo Holdings A/S, Canaan Partners and TPG Biotech
  • on its acquisition of a minority stake in Ambio Holdings, Inc., a global peptide API CDMO, from MVM Partners, a specialist healthcare fund
• Colfax Corporation in its $3.15 billion acquisition of DJO Global Inc.
• CoreLogic®, a portfolio company of Stone Point Capital and Insight Partners, in its add-on acquisition of ClosingCorp, an intelligence source for closing costs and service providers in the U.S. residential real estate industry
• Danaher Corporation (NYSE: DHR) in the $750 million sale of its label-free biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses to Sartorius AG 
• EQT Infrastructure IV in its agreement to acquire EdgeConneX, a global data center provider serving the fast growing Hyperscale and Edge ecosystems, from an investor group led by Providence Equity Partners
• EQT Partners AB, along with Public Sector Pension Investment Board and Luxinva SA, a subsidiary of Abu Dhabi Investment Authority, in the acquisition of Nestle Skin Health SA from Nestle SA for an enterprise value $10.11 billion (CHF 10.200 billion)
• Fortive Corporation in its:
  
  • combination of its Tektronix Video business, a global leader in video test, with Telestream, a leading provider of digital media tools and workflow solutions
  • $2 billion acquisition of Accruent
  • 770 million acquisition of Landauer, Inc.
• General Motors and GM Cruise Holdings LLC, GM’s autonomous vehicle (AV) business, in a series of transactions including:
  
  • a $2.25 billion investment from the SoftBank Vision Fund, at a $11.5 billion valuation
  • a $2.8 billion investment from Honda, at a $14.6 billion valuation
  • a $1.15 billion investment from a group comprising institutional investors, including funds and accounts advised by T. Rowe Price Associates, Inc., and existing partners General Motors, SoftBank Vision Fund and Honda, at a $19 billion valuation
• GTCR-backed Maravai LifeSciences in its acquisition of MockV Solutions, a biotechnology company developing non-infectious viral clearance prediction products
• Ingersoll Rand, Inc. (NYSE:IR) in its carve-out sale of its High Pressure Solutions (HPS) business to American Industrial Partners, an operationally oriented private equity firm
• Linden Capital Partners-backed Z-Medica, a manufacturer of hemostatic products, in its $525 million sale to Teleflex (NYSE: TFX), a leading global provider of healthcare supplies and services
• LLamasoft in its:
  
  • acquisition of Opex Analytics, a Chicago-based provider of artificial intelligence (AI) solutions to Fortune 500 companies
  • sale to Coupa Software (NASDAQ: COUP), a leader in Business Spend Management (BSM), for approximately $1.5 billion
• Pamplona Capital Management in its $5 billion acquisition of PAREXEL International
• Schlumberger (NYSE: SLB) in its agreement with Liberty Oilfield Services (NYSE: LBRT) to acquire Schlumberger’s onshore hydraulic fracturing business in the U.S. and Canada (OneStim®), including its pressure pumping, pumpdown perforating wireline and Permian frac sand businesses, in exchange for a 37% equity interest in Liberty, valued at $448 million
• Solara Medical Supplies, LLC in its agreement to be acquired by AdaptHealth Corp. (Nasdaq: AHCO), a provider of home medical equipment, supplies and related services
• Thoma Bravo and JLL Partners in Thoma Bravo’s sale of MedeAnalytics, a cloud-based enterprise analytics solutions provider for health systems and health plans, to JLL Partners
• Thomas H. Lee Partners in its:
  
  • acquisition of Bazaarvoice, a provider of software solutions that collect and display user-generated content for online brands and retailers, from Marlin Equity Partners
  • acquisition of Insurance Technologies, a provider of sales and regulatory automation solutions for the insurance and financial services industries, from NexPhase Capital
• Warburg Pincus in its strategic investment in Global Healthcare Exchange (GHX), an operator of the healthcare industry’s largest cloud-based trading network that connects those who buy, sell and use products needed to deliver patient care
• Vericast, an affiliate of MacAndrews & Forbes, in its $420 million carve-out sale of its RetailMeNot business, an operator of a digital coupon marketplace, to J2 Global, Inc. (NASDAQ: JCOM)

Capital Markets, SPAC Transactions & IPOs

• Blackstone, in its US$400 million subscription of H shares convertible bonds in Hong Kong-listed YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKSE: 1558)
• Everest Medicines Limited, (HKSE: 1952), a biopharmaceutical company that integrates licensing, clinical development and commercialization of therapies for the needs in Greater China and emerging Asia Pacific, in its $515 million IPO on the Hong Kong Stock Exchange
• FinServ Acquisition Corp. (NASDAQ: FSRV) in its merger with Katapult Holding, an e-commerce focused financial technology company
• Greenbriar Equity Group-led investment group in a $500 million Series A preferred stock financing for Uber Freight, the logistics arm of Uber Technologies (NYSE: UBER)
• JHBP (CY) Holdings (HKSE: 6998), a holding company for Genor Biopharma, a commercial-ready biopharmaceutical company that focuses on developing and commercializing oncology and autoimmune drugs, in its $400 million IPO
• Stable Road Acquisition Corp. (Nasdaq: SRAC, SRACU, SRACW), a special purpose acquisition company sponsored by an affiliate of Stable Road Capital, in its $1.2 billion business combination with commercial space company Momentus Inc.
• TPG in its $450 million investment in Vice Media

Licensing, Joint Ventures, Strategic Alliances and Collaborations

• Bain in its negotiation of the brand license agreement with Virgin Enterprises in connection with Bain’s $3.5 billion acquisition of Virgin Australia
• Boehringer Ingelheim on its amended and restated alliance agreement with Eli Lilly and Company (NYSE: LLY) related to Jardiance®, Trajenta® and Basaglar®
• Eli Lilly in its research collaboration and licensing agreement with Lycia Therapeutics, Inc., focused on the discovery, development and commercialization of novel targeted therapeutics using Lycia's proprietary lysosomal targeting chimera protein degradation technology. The deal included an upfront payment, equity investment, over $1.6 billion in potential milestone payments, and tiered royalties from sales
• GrubHub (NYSE: GRUB), the nation’s leading online and mobile food ordering company, in its $200 million private placement minority investment from and partnership arrangement with Yum! Brands (NYSE: YUM) to expand GrubHub’s U.S. delivery network
• Open Invention Network, a joint venture of eight companies (Google, IBM, NEC, Philips, Red Hat, Sony, SUSE, and Toyota) and 3400+ licensing participants, which is the largest patent non-aggression community and supports the freedom of action with respect to the Linux operating system
• Samumed LLC in its exclusive license agreement with United Therapeutics Corporation for the North American rights to Samumed's SM04646, which is being developed for the treatment of idiopathic pulmonary fibrosis (IPF)
• Stonepeak Partners in its formation of Levo Mobility LLC (Levo), a joint venture formed by Nuvve Holding Corp., Stonepeak Partners, and Evolve Transition Infrastructure LP that provides Fleet-as-a-Service (FaaS) solutions enabling fleets to switch to electric vehicles (EVs) quickly with no upfront costs and full financing options. Levo will utilize Nuvve’s V2G technology and committed capital from Stonepeak and Evolve to offer Fleet-as-a-Service for school buses, last-mile delivery, ride hailing and ride sharing, and municipal services. Stonepeak and Evolve plan to deploy up to an aggregate $750 million capital commitment

Restructuring

• Akorn, Inc., a leading specialty pharmaceutical company, in its sale to various lender groups in connection with its Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware
• Pier 1 Imports, Inc. and its subsidiaries in their Chapter 11 cases in the United States Bankruptcy Court for the Eastern District of Virginia. Pier 1 is a publicly-traded omnichannel retailer specializing in home furnishings and décor with 923 stores in the United States and Canada